result
similar
increas
cytokin
concentr
observ
asthmat
nonasthmat
patient
howev
higher
concentr
chemokin
observ
asthmat
patient
virusinfect
monocyt
cultur
show
similar
cytokin
chemokin
profil
observ
patient
conclus
circul
cytokin
profil
induc
acut
viral
lung
infect
relat
asthmat
statu
except
chemokin
alreadi
increas
asthmat
statu
monocyt
could
play
import
role
increas
circul
concentr
cytokin
found
respiratori
viral
infect
pleas
cite
paper
giuffrida
et
al
increas
cytokinechemokin
serum
asthmat
nonasthmat
patient
viral
respiratori
infect
background
respiratori
viral
infect
induc
differ
cytokinechemokin
profil
lung
tissu
signific
influenc
patient
asthma
littl
inform
system
cytokin
statu
viral
respiratoryinfect
asthmat
patient
compar
nonasthmat
patient
object
aim
studi
determin
chang
circul
cytokin
tnfa
chemokin
monocyt
chemoattract
rant
regul
activ
normal
cell
express
secret
patient
asthmat
versu
nonasthmat
background
respiratori
syncyti
viru
parainfluenza
viru
adenoviru
respiratori
infect
addit
human
monocyt
cultur
incub
respiratori
virus
determin
cytokin
chemokin
profil
patientsmethod
patient
asthmat
n
nonasthmat
n
histori
respiratori
infect
respiratori
syncyti
viru
parainfluenza
adenoviru
studi
healthi
individu
similar
age
sex
n
use
control
cytokinechemokin
content
blood
cultur
supernat
determin
elisa
monocyt
isol
hystopaqu
gradient
cocultur
abovement
virus
viral
respiratori
tract
infect
profound
effect
asthma
respiratori
viral
infect
signific
influenc
asthmat
patient
viral
respiratori
infect
found
associ
asthma
exacerb
infect
associ
wheez
event
multipl
includ
infect
respiratori
syncyti
viru
rsv
human
rhinoviru
metapneumoviru
parainfluenza
coronaviru
virus
previou
studi
shown
differ
bronchoalveolar
lavag
cytokin
profil
nonasthmat
asthmat
patient
relat
type
cellular
infiltr
observ
suggest
immun
respons
relat
atop
statu
howev
circul
cytokin
respons
viral
respiratori
infect
asthmat
nonasthmat
statu
littl
studi
regard
circul
blood
level
sever
cytokin
report
increas
viral
respiratori
tract
infect
cytokin
may
repres
inflammatori
marker
differ
profil
asthmat
nonasthmat
patient
sever
cytokin
describ
play
import
role
pathogenesi
asthma
tnfa
rant
gmcsf
eotaxin
ifnc
asthma
one
heterogen
respiratori
diseas
may
also
demonstr
system
pattern
beyond
respiratori
system
determin
serum
cytokin
level
asthmat
patient
could
potenti
util
diagnosi
asthma
certain
phenotyp
predict
attack
choic
treatment
addit
cytokinechemokin
profil
increas
system
concentr
molecul
could
activ
circul
leukocyt
deleteri
effect
lung
therefor
aim
studi
describ
chang
sever
inflammatori
cytokin
tnfa
cytokin
chemokin
monocyt
chemoattract
rant
regul
activ
normal
cell
express
secret
system
circul
acut
viral
infect
patient
asthmat
nonasthmat
background
relationship
respiratori
infect
type
upper
lower
type
viru
infect
addit
determin
role
monocyt
circul
cytokin
profil
cytokinechemokin
profil
viralmonocyt
interact
studi
male
femal
patient
n
present
clinic
diagnosi
acut
respiratori
infect
ari
asthmat
patient
without
preexist
asthma
studi
inclus
criteria
individu
least
one
respiratori
symptom
cough
wheez
run
nose
sneez
suspect
profession
physician
viral
infect
asthmat
patient
select
accord
criteria
global
initi
asthma
gina
program
asthmat
crisi
present
least
month
previou
blood
sampl
taken
addit
suggest
clinic
diagnosi
pneumonia
bronchiti
viral
infect
rsv
parainfluenza
adenoviru
confirm
presenc
viru
specimen
nasopharynx
bronchoalveolar
lavag
viral
replic
demonstr
cell
cultur
protocol
nation
institut
health
usa
healthi
individu
similar
age
sex
n
studi
control
blood
sampl
obtain
patient
control
serum
store
use
exclud
individu
cardiac
diseas
immunodefici
chronic
inflammatori
diseas
patient
treat
antibiot
antialerg
steroid
blood
sampl
obtain
ethic
committe
instituto
de
investigacion
cl
dr
erico
negrett
fonacit
caraca
venezuela
approv
studi
written
inform
consent
obtain
patient
control
prior
blood
collect
nasopharynx
bronchoalveolar
sampl
patient
sonic
centrifug
supernat
ad
cell
cultur
previous
cell
grown
confluenc
eagl
minimum
essenti
medium
mem
contain
fb
antibioticantimycot
two
wash
pb
supernat
ad
cell
cultur
cultur
incub
hour
mem
contain
fb
antibiot
antimycot
ad
cultur
incub
co
hour
supernat
cultur
centrifug
store
sourc
viru
viral
cell
cultur
infect
rsv
parainfluenza
adenoviru
determin
direct
immunofluoresc
use
commerci
kit
light
diagnost
simulfluor
respiratori
screen
kit
chemicon
internacion
temecula
ca
usa
quantif
mononuclear
leukocyt
obtain
heparin
venou
blood
five
healthi
adult
donor
cell
isol
densiti
gradient
centrifug
hystopaqu
sigma
chemic
co
st
loui
mo
usa
cell
suspend
cellml
rpmi
supplement
uml
penicillin
lgml
streptomycin
fb
incub
humidifi
atmospher
co
incub
adher
cell
enrich
wash
away
unattach
cell
twice
wash
mean
adher
cellswel
obtain
monocyt
cultur
donor
infect
moi
viru
obtain
infect
cell
cultur
supernat
rsv
parainfluenza
adenoviru
monocyt
cultur
cell
cultur
supernat
without
viru
use
neg
control
hour
supernat
collect
cytokin
chemokin
determin
perform
use
elisa
result
express
pgmg
cellular
protein
monocyt
viru
infect
determin
direct
immunofluoresc
light
diagnost
simulfluor
respiratori
screen
kit
chemicon
internacion
ca
usa
valu
express
mean
ae
standard
deviat
signific
differ
test
anova
bonferroni
post
hoc
test
correl
analysi
perform
use
pearson
correl
twotail
p
valu
consid
statist
signific
age
laboratori
find
studi
group
shown
tabl
increas
level
ige
observ
asthmat
patient
compar
nonasthmat
patient
control
gener
serum
level
tnfa
rant
increas
patient
acut
viral
respiratori
infect
figur
cytokin
express
similar
asthmat
nonasthmat
patient
chemokin
rant
significantli
increas
asthmat
patient
compar
control
nonasthmat
patient
asthmat
patient
bronchiti
found
figur
gener
serum
chemokin
rant
lower
level
bronchiti
pneumonia
figur
infect
rsv
parainfluenza
viru
adenoviru
similar
cytokin
induct
howev
rsv
induc
signific
increas
express
chemokin
figur
vitro
infect
normal
monocyt
cultur
rsv
parainfluenza
viru
adenoviru
induc
increas
cytokin
concentr
cultur
supernat
rsv
parainfluenza
viru
capabl
induc
signific
increas
express
figur
signific
increas
express
found
patient
serum
control
ae
viral
ari
ae
pgml
viralinfect
monocyt
cultur
control
ae
rsv
ae
parainfluenza
ae
adenoviru
ae
pg
mg
protein
express
posit
correl
express
r
p
correl
studi
serum
cytokin
serum
ige
level
associ
age
donor
cytokinechemokin
product
respiratori
tract
frequent
primari
site
viral
infect
may
result
develop
acut
respiratori
distress
syndrom
ard
current
understand
pathogenesi
ard
suggest
degre
inflammatori
respons
sustain
leukocyt
activ
may
determin
clinic
evolut
ard
lung
inflammatori
event
alveolar
compartment
could
lost
allow
passag
cytokin
releas
bloodstream
organ
pulmonari
endothelium
invers
lung
bloodstream
cytokin
especi
tnfa
import
role
lung
dysfunct
studi
patient
viral
ari
increas
serum
level
proinflammatori
cytokin
tnfa
cytokin
chemokin
rant
suggest
complex
immun
interact
viral
respiratori
infect
sourc
cytokin
may
cell
local
lung
tissu
regard
epitheli
cell
mast
cell
basophil
monocytemacrophag
lymphocyt
could
secret
divers
type
cytokin
chemokin
tnf
rant
lung
tissueviru
interact
howev
studi
monocyt
cultur
infect
rsv
adenoviru
parainfluenza
viru
capabl
reproduc
similar
cytokin
chemokin
profil
observ
virusinfect
patient
suggest
part
circul
monocyt
could
sourc
serum
cytokin
chemokin
accordingli
chemokin
chemokin
receptor
induc
effect
rsv
monocytemacrophag
cultur
report
alveolar
compartment
could
lost
viralinduc
lung
injuri
combin
lung
circul
monocyt
cytokin
chemokin
product
contribut
increas
serum
level
found
studi
patient
ari
mainli
infect
rsv
human
respiratori
syncyti
viru
ubiquit
respiratori
viru
caus
seriou
lower
respiratori
tract
diseas
infant
young
children
worldwid
previou
studi
shown
rsv
infect
modul
cytokin
tnfa
gmcsf
chemokin
rant
chemokin
receptor
express
vivo
vitro
suggest
particular
cytokin
express
profil
may
indic
diseas
sever
accordingli
studi
serum
rsvinfect
patient
rsvinfect
monocyt
cultur
increas
level
tnfa
rant
effect
probabl
common
featur
respiratori
viru
infect
similar
serum
cytokinechemokin
level
viral
cytokin
induc
effect
monocyt
cultur
observ
adenoviru
parainfluencia
viru
infect
addit
infect
rsv
could
risk
factor
lung
diseas
persist
cytokin
chemokin
fulli
recov
rsvinfect
patient
provid
substratum
develop
subsequ
asthma
regardless
cytokin
product
sourc
harm
effect
lung
initi
injuri
lung
tissu
could
releas
factor
contribut
inflamm
includ
chemokin
interleukin
prostaglandin
pge
studi
found
increas
express
tnfa
rant
serum
patient
viral
respiratori
infect
cytokin
could
deleteri
effect
lung
tissu
tnfa
induc
apoptosi
lung
tissu
result
emphysema
activ
sever
proinflammatori
event
induc
neutrophil
inflammatori
respons
respiratori
disord
releas
mani
cytokin
chemokin
addit
induc
eosinophil
accumul
b
cell
growth
factor
regard
studi
activ
profil
observ
shown
increas
product
cytokin
increas
allerg
airway
inflamm
increas
concentr
circul
chemokin
found
asthmat
patient
may
import
leukocyt
recruit
lung
tissu
rant
involv
chemoattract
eosinophil
monocyt
tlymphocyt
therefor
high
relev
asthma
involv
recruit
regulatori
effector
leukocyt
monocyt
lymphocyt
basophil
tissu
therefor
chemokin
could
play
import
role
asthma
pathogenesi
ige
multifunct
role
pathogenesi
allerg
inflamm
besid
involv
igemedi
degranul
mast
cell
basophil
also
involv
activ
macrophagemonocyt
stimul
cell
involv
local
infiltr
secret
cell
show
patholog
evid
epitheli
damag
like
serv
amplifi
tissu
inflamm
case
asthma
bronchial
epitheli
damag
eg
damag
caus
virus
eosinophil
cation
protein
cytokin
releas
airway
epithelium
believ
play
import
role
pathogenesi
airway
inflamm
studi
increas
level
ige
found
patient
asthmat
background
associ
increas
product
circul
suggest
possibl
role
ige
increas
level
cytokin
pathogenesi
asthma
howev
correl
analysi
fail
demonstr
statist
signific
ige
valu
previou
report
shown
differ
bronchoalveolar
lavag
cytokin
profil
chronic
obstruct
pulmonari
diseas
copd
asthma
regard
profil
cytokin
express
copd
differ
asthma
probabl
relat
type
cellular
infiltr
observ
two
diseas
thu
asthma
infiltr
eosinophil
involv
product
usual
found
copd
neutrophil
chemokin
proinflammatori
cytokin
tnfa
play
promin
role
studi
bronchoalveolar
lavag
cytokin
profil
analyz
howev
circul
cytokin
profil
show
differ
express
proinflammatori
cytokin
profil
asthmat
nonasthmat
patient
suggest
respons
viru
infect
relat
atop
statu
addit
level
ige
correl
express
serum
level
chemokin
observ
increas
asthmat
patient
suggest
increas
cellular
infiltr
monocyt
neutrophil
eosinophil
tissu
level
accordingli
import
role
chemokin
virusassoci
asthma
exacerb
report
previou
report
also
shown
differ
inflammatori
respons
rsv
asthmat
epithelium
cultur
compar
nonasthmat
epithelium
compar
studi
asthmat
nonasthmat
monocyt
cultur
perform
studi
howev
cytokinechemokin
induc
effect
rsv
virus
monocyt
cultur
remain
similar
circul
cytokin
profil
asthmat
nonasthmat
patient
suggest
possibl
similar
respons
asthmat
nonasthmat
monocyt
cultur
viru
infect
nevertheless
rule
differ
cellular
respons
viralinfect
asthmat
monocyt
cultur
differ
chemokin
rant
profil
observ
rsvtreat
monocyt
cultur
asthmat
nonasthmat
patient
unexpect
find
studi
found
similar
level
asthmat
nonasthmat
patient
asthmat
patient
profil
rsv
viru
clear
explan
find
howev
previou
exposur
rsv
sensit
nonasthmat
airway
increas
cytokin
respons
regard
rsv
infect
neonat
lead
inflammatori
airway
diseas
character
airway
hyperreact
peribronchi
perivascular
inflamm
subepitheli
fibrosi
adult
conclus
present
studi
demonstr
main
characterist
serum
cytokin
profil
healthi
asthmat
nonasthmat
patient
serum
cytokin
pattern
differ
nonasthmat
asthmat
individu
higher
valu
chemokin
observ
asthmat
patient
furthermor
cytokin
profil
observ
virusmonocyt
cultur
suggest
role
cell
increas
circul
cytokineschemokin
patient
precis
mechan
regard
system
cytokin
might
involv
drive
viral
respiratori
infect
process
remain
elus
